Dr Pulin Kumar Gupta Associate Professor Department of Medicine Incharge HIV/ART Centre PGIMER, Dr RML Hospital NEW DELHI INDIA.

Slides:



Advertisements
Similar presentations
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2013 Living (Prevalence)
Advertisements

Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
The hidden HIV epidemic: what do mathematical models tell us? The case of France Virginie Supervie, Jacques Ndawinz & Dominique Costagliola U943 Inserm.
The HIV/AIDS Epidemic © 2005 John B. Pryor Illinois State University.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
VITAMEN D DEFICIENCY IN SAUDI ARABIA THE SILENT EPIDEMIC
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
IDF-EMME Region Meeting September 7-9, 2007 Cairo, Egypt.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Epidemiology of HIV among Asians & Pacific Islanders Reported in Florida, Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Annual.
Epidemiology of HIV Among Asians and Pacific Islanders Reported in Florida, Through 2014 Florida Department of Health HIV/AIDS Section Division of Disease.
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
HIV/AIDS in Michigan January 1, 2010 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases Bureau.
Chapter 1: An Overview of the HIV/AIDS Epidemic Module 1, Chapter 1.
1FHI 360 Nigeria. 2USAID Nigeria
Materials and methods Design Open-label, randomized trial, February 2010 to May 2011, avoiding the summer period Participants recruited from a primary.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
THE EFFECTS OF INTERMITTENT VITAMIN D3 SUPPLEMENTATION ON MUSCLE STRENGHT AND METABOLIC PARAMETERS IN POSTMENOPAUSAL WOMEN WITH TYPE 2 BIABETES: A RANDOMIZED.
Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 15/10/58 1.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients Dr. Mya Thandar.
Vani Gandhi, MD Attending Physician Center for Comprehensive Care Director of Integrative Medicine St. Luke’s-Roosevelt Hospital Center Evaluation of Vitamin.
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
Complications of HIV in perinatally infected adolescents and young adults in resource-poor settings Philippa Musoke MBChB PhD Department of Paediatrics.
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
HIV Disease and Hepatitis C Virus (HCV) Co-Infection – Florida, 2011 HIV/AIDS & Hepatitis Program - Surveillance Section HIV Disease data from 1981 through.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
SOUTH CAROLINA EPIDEMIOLOGIC PROFILE What is the Epi Profile? The HIV/AIDS Epidemiologic Profile is a document that: Describes the HIV/AIDS epidemic.
Florida Department of Health HIV/AIDS & Hepatitis Program Annual data trends as of 12/31/2012 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
AIDS Cases with TB Florida 2013 TB Created: 12/27/13 Revision: 10/16/14 To protect, promote and improve the health of all people in Florida through integrated.
Epidemiology of HIV Infection Trends Among Adults Living in Rural and Non-Rural Counties in Florida (excl DOC*) Diagnosed through 2014 Created:12/04/14.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
Florida Department of Health HIV/AIDS Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2014 Living (Prevalence)
Florida Department of Health HIV/AIDS & Hepatitis Program Annual data trends as of 12/31/2011 Living (Prevalence) data as of 05/16/2012 Epidemiology of.
To protect, promote and improve the health of all people in Florida through integrated state, county, and community efforts. Created: 12/04/14 Revision:
HCV Co-infection is Associated with a High Risk of Osteoporotic Fractures Among HIV Patients Roger Bedimo, MD; Henning Drechsler, MD; Song Zhang, PhD;
Chicago Department of Public Health Richard M. Daley Mayor Bechara Choucair, MD Commissioner CDPH – STI/HIV Surveillance, Epidemiology and Research Section.
HIV & AIDS GENERAL AWARENESS. Why should you know about HIV & AIDS ? HIV infection is preventable with correct knowledge and adoption of safe practices.
AIDS Cases with Tuberculosis – Florida, 2014 TB Created: 09/25/15 Revision: 01/26/16 To protect, promote and improve the health of all people in Florida.
Epidemiology of HIV Among Asians and Pacific Islanders Reported in Florida, Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division.
Saleem Jessani 1, Rasool Bux 1 and Tazeen H. Jafar 1,2. 1 Aga Khan University, Karachi, Pakistan 2 Duke-NUS Graduate Medical School, Singapore Socio-demographic.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Linkages between CDs & NCDs: The African context Dr Frank J Mwangemi ICASA 2011: 5 th December 2011 Addis Ababa, Ethiopia.
Problems of HIV Infection in the HAART Era Akihiko Suganuma M.D. Tokyo Metropolitan Komagome Hospital Department of Infectious Diseases.
QUALI DIFFERENZE IN RAPPORTO AL SESSO NELLA COINFEZIONE HCV/HIV? I DATI ITALIANI DALLA COORTE ICONA Antonella Cingolani Clinica Malattie Infettive, UCSC,
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
HIV Epidemic in Malaysia. HIV BY AGE GROUPS - MALAYSIA.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
ADVERSE OUTCOMES OF TREATING HIV-TB
The magnitude of hepatic enzyme rise and it’s correlation with the severity of Dengue Hemorrhagic Fever Muhammad Abdur Rahim 1, Khwaja Nazim Uddin 2, AKM.
Baseline characteristics and effectiveness results
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
A. Stepanov, A. Kruk, N. Polovinkina, A. Vinogradova
HIV-1 PLASMA VIRAL LOAD IN TREATMENT NAÏVE HIV-1 PATIENTS
ASSOCIATION OF CLINICAL AND BIOCHEMICAL FACTORS WITH SERUM TESTOSTERONE LEVELS IN TYPE 2 DIABETIC MALES Ravi Kumar Meena, Debasish Chaudhury, Amita.
Dr Sunil Kumar Nanda, Bharathy N, Dr Lopamudra Ray
Presenter : For : Dr. Dhananjay Gupta API-DSC 2016
Vitamin D status and cardio-metabolic risk factors in Saudi Arabia
DOES HIV/ HEPATITIS COINFECTION AFFECT PEOPLE ACCESSING CARE FOR HIV
Table 1: New HIV diagnoses, by UK country,
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Hepatitis C in the HIV-infected patient
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Switch to DTG-containing regimen
Public Health Implications
Presentation transcript:

Dr Pulin Kumar Gupta Associate Professor Department of Medicine Incharge HIV/ART Centre PGIMER, Dr RML Hospital NEW DELHI INDIA

Vitamin D levels in HIV infected patients and its correlation with severity of disease

AIDS epidemic in India Total > 40 Lakh people living with HIV/AIDS Prevalence - 0.31% -2.5 lakh new infection every year (2000) -1.2 lakh new infection every year (2009) Vulnerable groups and areas Heterosexual- prostitute, truck drivers, single male migrants Homosexual- eunuch, MSM Injecting drug user, Iatrogenic OI (opportunities infection) leading causes of deaths Recent changes in trends of Mortality/Morbidity – Atherosclerotic diseases Complications of ART Osteoporosis Depression and suicides

Significance of vitamin D in Health Sources -direct sunlight/diet Receptors of vitamin D in body Bone/Skeletal muscles Brain/Prostate/ Breast/Colon Immune cells Causes of vitamin D deficiency Advanced age Lack of sunlight exposure Residence at higher altitude Dark Skin pigmentation Malnutrition Obesity Medications Vitamin D Status in general population 36% / 57% in USA 60% / 75% in India

Role of vitamin D in IMMUNITY Vitamin D and immune system Innate and adaptive immunity Macrophage activation VDR’ s (Vitamin D receptors) Effect on Toll like receptors & cathelicidin peptide IL-37 Human defensin 2 Decrease T cell proliferation

Vitamin D and HIV Prevalence of hyporvitaminosis in HIV/AIDS Coodley et al (AIDS 1993) → 11% Kuehn EW (Germany 1999) → 45% Borderi- M (Italy 2011) → 7% & 54% Adeyemi (USA 2011) → 60% Mehtas (India 2012) → 66% Causes of low vitamin D in HIV/AIDS patients Malnutrition ART/concomitant Infections Decreased sun exposure Affect of hypovitaminosis-D on Health in these patients Osteoporosis and fractures Depression/Dementia CAD/PVD Increased OI’s Anaemia

Aims and Objective To study status of vitamin D levels in HIV infected individuals. To assess the correlation if any between levels of vitamin D and CD4 counts (i.e. severity of disease) and ART (Anti Retroviral Treatment) in these group of patients.

Material and Methods Study Design – cross sectional, observational study Study Place – tertiary healthcare centre, PGIMER Dr RML Hospital New Delhi, India Study group – HIV patients with or without ART (Total 170 patients) Study duration – 70 weeks

Material and Methods Inclusion criteria- documented HIV infection confirmed by a series of 3 tests as per NACO guidelines Exclusion criteria- medications/type 2 diabetes / drugs/vitamin D supplementation/abnormal KFT or LFT Definitions used - Vitamin D deficiency -25-OH Vitamin D levels< 20 ng/ml Vitamin D insufficiency -25-OH levels 21-29 ng/ml

Observations and Result - No of Patients - - Age Groups - Distribution of patients in age groups Sex distribution of patients Proportion of patients on ART Total Patients – 170 [134 (79%) males & 36 (21%) females]

Observations & Result continued.. Characteristic Minimum Maximum Mean Std deviation Age (years) 19 70 35.54 8.04 Duration of disease (years) 00 13.00 2.28 2.09 SBP (mmHg) 100 134 115.71 9.31 DBP (mmHg) 60 84 75.09 5.75 HB (gm/dl) 4.70 16.00 11.07 2.32 Urea (mg /dl) 12.00 65.00 24.39 9.28 S. creatinine (mg/dl) 0.30 1.50 0.79 0.22 FBG (mg/dl) 50.00 123.00 87.64 12.77 PPBG (mg/dl) 112.00 186.00 136.41 12.40 Total cholesterol (mg/dl) 34.00 425.00 148.51 53.05 Triglyceride (mg/dl) 10.00 714.00 149.38 98.16 LDL (mg/dl) 199.00 91.08 32.42 VLDL (mg/dl) 144.00 30.83 16.25 HDL (mg/dl) 12.20 94.00 37.04 14.20 Calcium (mg/dl) 5.70 10.70 8.39 0.78 CD4 Counts(mm3) 3.00 1141.00 249.30 186.74 Vitamin D ( ng/ml) 3.44 31.20 11.26 5.49 Characteristics of patients

Observations & Result continued.. HBsAg (+) – 10 (5.88%) Anti HCV – 1 (0.6%) VDRL (+) – 7( 4.12%) - No of Patients - - Co -infection - No of patients having co infection

Observations & Result continued.. Group CD4 Counts HIV associated immunodeficiency Number(%) of patients Mean ± SD CD4 Counts Vitamin D (ng/ml) A <200/mm3 Severe 81 (47.65%) 109.78 ± 51.40 10.43 ± 4.98 B 200-349/mm3 Advanced 53 (31.18%) 269.98 ± 45.24 11.89 ± 6.01 C ≥350/mm3 Mild or None 36 (21.2%) 532.78 ± 175.90 12.21 ± 5.64 Total 170 (100%) 249.30 ± 186.74 11.26 ± 5.49 Vitamin D levels in different groups according to level of immunodeficiency

Observations & Result continued.. - No of Patients - - Groups - Distribution of patients according to vitamin D levels in groups Groups ≤ 20 ng/ml 21-29 ng/ml ≥ 30 ng/ml A 77 (95%) 4 (5%) 0 (0%) B 49 (92.4%) 3 (5.6%) 1 (1.8%) C 33 (91.6%) 2 (5.5%) 1 (2.7%) Total 159 (93.5%) 9 (5.2%) 2 (1.1%) Number of patients according to Vitamin D levels in groups

Observations & Result continued.. Vitamin D deficiency = 93.5% Vitamin D insufficiency = 5.2% Hypovitaminosis = 98.7%

Observations & Result continued.. Groups CD4 counts in male Vitamin D levels in males (ng/ml) CD4 counts in female Vitamin D levels in females (ng/ml) A 106.56 ± 48.87 10.82 ± 5.19 123.93 ± 61.17 8.72 ± 3.55 B 268.03 ± 48.29 12.31 ± 5.96 275.43 ± 36.45 10.72 ± 6.25 C 521.38 ± 186.44 11.83 ± 4.94 580.00 ± 122.68 13.79 ± 8.25 Vitamin D in male and female in groups

Observations & Result continued.. Diet Non vegetarians Vegetarians P Value CD4 counts (mm3) 246.64 ± 19.59 223.13 ± 17.21 0.405 Vitamin D (ng/dl) 11.34 ± 5.52 9.65 ± 4.66 0.397 Calcium (mg/dl) 8.75 ± 0.78 8.37.00 ± 0.82 0.183 Total 11.26 ± 5.49 249.30 ± 186.74 Characteristics of patients according to diet

Observations & Result continued.. Characteristic On ART ART Naïve P Value CD4 counts (mm3) 274.28 ± 20.3 175.51 ± 23.27 0.002 Vitamin D levels (ng/ml) 11.54 ± 5.97 10.45 ± 3.63 0.263 LDL(mg/dl) 97.74 ± 30.70 71.39 ± 29.53 <0.01 Total Cholesterol(mg/dl) 159.16 ± 52.20 117.04 ± 42.36 Characteristics of patients on ART and ART naive

Discussion/Limitations of our study High prevalence of hypovitaminosis-D in Indian HIV patients (95% Vs 70%) Correlation of low vitamin D levels with CD4/ART Consequences of low vitamin D levels in HIV/AIDS patients Inference and advice

Thank You